Equities

BIOLASE Inc

BIOL:QBB

BIOLASE Inc

Actions
  • Price (USD)0.055
  • Today's Change0.000 / -0.18%
  • Shares traded33.57k
  • 1 Year change-96.78%
  • Beta0.6638
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

BIOLASE, Inc. is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company's systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. It offers two categories of laser system products: Waterlase (all-tissue) systems and diode (soft-tissue) systems. The Company's all-tissue Waterlase dental laser systems consist of its flagship Waterlase iPlus, Waterlase Express, and Waterlase MDX. Its soft tissue diode laser systems consist of the Epic X, Epic Hygiene, Epic Q, and Epic 10 diode lasers that perform soft tissue, hygiene, cosmetic procedures, teeth whitening, and provide temporary pain relief. Epic X, and Epic 10 systems feature its 940 nanometer wavelength with patented pulse technology called ComfortPulse.

  • Revenue in USD (TTM)46.10m
  • Net income in USD-36.19m
  • Incorporated1987
  • Employees157.00
  • Location
    BIOLASE Inc27042 Towne Centre Drive, Suite 270FOOTHILL RANCH 92610United StatesUSA
  • Phone+1 (949) 361-1200
  • Fax+1 (949) 273-6677
  • Websitehttps://www.biolase.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Catheter Precision Inc436.00k-9.49m1.26m14.00--0.0238--2.89-12.95-12.950.604618.900.01410.55743.8931,142.86-30.71---33.63--92.20---2,176.84--0.098--0.0434--3,057.14---165.67------
Hawkeye Systems Inc0.00-804.18k1.58m44.00---------0.1186-0.11860.00-0.290.00-------66.07-330.11-----------218.49---2.7810.45------4.85------
Tivic Health Systems Inc1.11m-6.75m1.67m9.00--0.3978--1.50-4.33-4.330.54690.67790.23730.915676.76123,666.70-143.94---176.98--27.85---606.47--6.59--0.00---36.09--18.34------
NanoVibronix Inc3.37m-2.82m1.92m10.00--0.6762--0.5696-1.32-1.321.501.020.70810.43112.05337,300.00-59.12-116.16-122.41-169.3664.5750.47-83.49-570.471.16-14.770.00--203.5948.3331.88---34.02--
BIOLASE Inc46.10m-36.19m2.01m157.00------0.0437-11.65-11.653.32-0.06361.312.558.73293,611.50-54.64-49.28-185.36-85.8033.0135.27-41.65-50.720.3589-6.001.19--1.451.27-30.39--18.63--
Avinger Inc7.43m-15.34m2.19m68.00--0.2361--0.2952-12.13-12.135.834.050.4341.238.03109,250.00-113.20-70.93-1,387.68-131.5719.9630.87-260.86-208.911.20-11.660.3428---7.51-0.673632.76---24.21--
Arch Therapeutics Inc148.17k-12.99m2.27m8.00------15.30-3.69-3.690.0383-2.830.100.0662--18,521.25-828.03-188.28---804.6339.58---8,276.08-26,945.920.0051-1.32----383.83---32.35---21.76--
Nuwellis Inc9.01m-22.81m2.35m59.00------0.261-181.60-181.6048.48-13.250.82921.527.30152,779.70-192.57-98.07-301.19-122.4860.2855.22-232.24-230.510.7119-1.52----3.7612.14-55.78--4.61--
Optimus Healthcare Services Inc1.89m-7.16m2.46m12.00------1.30-0.1744-0.17440.0454-0.18891.26--3.67157,291.70-477.28------85.93---379.51-----5.42----22.88---3.51------
Sonendo Inc37.46m-47.49m2.50m216.00--0.14--0.0668-0.5017-0.44360.39520.24530.4981.956.91173,421.30-63.14---78.26--35.04---126.79--1.73-8.540.5194--5.30---6.78------
Vycor Medical Inc1.36m-506.30k2.58m8.00------1.90-0.0155-0.01560.0417-0.10811.430.66945.08170,011.30-19.13-47.86----89.2389.60-13.38-35.420.0987-0.8001----19.43-0.654246.49---31.77--
SINTX Technologies Inc3.13m-8.60m2.59m43.00--0.2927--0.8271-271.52-271.5216.4411.820.18181.777.6372,697.67-50.01-45.71-62.67-57.3667.7258.47-275.14-681.801.79--0.0265--68.2994.2449.75--54.10--
Helius Medical Technologies Inc594.00k-8.84m2.61m22.00--0.4116--4.39-10.68-10.680.50421.980.06060.74864.4827,000.00-90.17-98.37-110.33-143.5712.7937.27-1,487.54-1,580.663.80--0.00---18.176.1437.11---41.95--
Invo Bioscience Inc5.77m-7.08m2.72m25.00------0.4706-3.24-3.242.440.35290.467712.0034.74230,781.20-57.44-94.63-116.03-151.4544.8974.91-122.80-343.110.2686-4.750.6588--267.3843.6226.24--87.09--
Heart Test Laboratories Inc18.60k-7.29m2.73m15.00--0.4568--146.82-5.65-5.650.00116.550.00350.0092--1,240.00-135.14---193.38--67.31---39,193.76--4.02-20.720.0777--261.17---3.95------
Data as of Sep 20 2024. Currency figures normalised to BIOLASE Inc's reporting currency: US Dollar USD

Institutional shareholders

3.32%Per cent of shares held by top holders
HolderShares% Held
S.H.N. Financial Investments Ltd.as of 13 Feb 20241.19m3.25%
XTX Markets LLCas of 30 Jun 202419.43k0.05%
Geode Capital Management LLCas of 31 Jul 20245.40k0.02%
Huntington National Bank (Investment Management)as of 30 Jun 20241.000.00%
Desjardins Securities, Inc.as of 30 Jun 20240.000.00%
Tower Research Capital LLCas of 30 Jun 20240.000.00%
Citadel Securities LLCas of 30 Jun 20240.000.00%
Qube Research & Technologies Ltd.as of 30 Jun 20240.000.00%
Kellett Wealth Advisors LLCas of 30 Jun 20240.000.00%
Virtu Americas LLCas of 30 Jun 20240.000.00%
More ▼
Data from 30 Jun 2024 - 29 Aug 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.